Toggle navigation
Home
Search
Services
Blog
Contact
About
A Randomized Controlled Phase II Clinical Trial of Modulation of Inter-261995129
Johns Hopkins University, Baltimore, MD, United States
Search grants from Johns Hopkins University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Genetics and quantum chemistry as tools for unknown metabolite identification
Cellular effects of carbon monoxide
Working Memory and Social Functioning in Schizophrenia
Career Development - Breast Cancer
Lh-Rh to Study the Pubertal Process
Recently added grants:
Mentoring Patient-Oriented Research to Prevent Injury in Older Adults
A Dyadic Approach to Perinatal Depression Treatment in Primary Care
Bruins in Genomics: Dental, Oral & Craniofacial Research Training Program (BIG DOC)
Discovery of PSD95 protein-protein interaction inhibitors as novel non-opioid analgesics
Investigating whole-body innate immune activation in Alzheimer's disease using PET imaging and immune profiling
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA095129-004
Application #
6828932
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Related projects
NIH 2003
N01 CA
A Randomized Controlled Phase II Clinical Trial of Modulation of Inter-261995129
/ Johns Hopkins University
NIH 2002
N01 CA
A Randomized Controlled Phase II Clinical Trial of Modulation of Inter-261995129
/ Johns Hopkins University
Comments
Be the first to comment on this grant